Bryan Harder

1.6k total citations · 1 hit paper
16 papers, 1.3k citations indexed

About

Bryan Harder is a scholar working on Molecular Biology, Genetics and Nutrition and Dietetics. According to data from OpenAlex, Bryan Harder has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Nutrition and Dietetics. Recurrent topics in Bryan Harder's work include Genomics, phytochemicals, and oxidative stress (7 papers), Glutathione Transferases and Polymorphisms (4 papers) and Glioma Diagnosis and Treatment (2 papers). Bryan Harder is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (7 papers), Glutathione Transferases and Polymorphisms (4 papers) and Glioma Diagnosis and Treatment (2 papers). Bryan Harder collaborates with scholars based in United States, France and United Kingdom. Bryan Harder's co-authors include Eli Chapman, Donna D. Zhang, Montserrat Rojo de la Vega, Pak Kin Wong, Tao Jiang, Donna D. Zhang, Tongde Wu, Tian Wang, Nhan L. Tran and Julie E. Lang and has published in prestigious journals such as Free Radical Biology and Medicine, Toxicology and Applied Pharmacology and Lara D. Veeken.

In The Last Decade

Bryan Harder

15 papers receiving 1.3k citations

Hit Papers

p62 links autophagy and Nrf2 signaling 2015 2026 2018 2022 2015 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan Harder United States 14 889 259 154 115 98 16 1.3k
Xifeng Li China 23 633 0.7× 208 0.8× 191 1.2× 90 0.8× 112 1.1× 103 1.8k
Chul Won Yun South Korea 20 660 0.7× 184 0.7× 192 1.2× 129 1.1× 120 1.2× 28 1.1k
Jianling Xie Australia 25 1.0k 1.2× 184 0.7× 218 1.4× 45 0.4× 164 1.7× 55 1.8k
Meriç A. Altinoz Türkiye 21 532 0.6× 110 0.4× 217 1.4× 165 1.4× 139 1.4× 89 1.2k
Ashutosh Shrivastava India 15 458 0.5× 138 0.5× 162 1.1× 93 0.8× 114 1.2× 61 1.1k
Lauren Diebold United States 13 1.0k 1.2× 132 0.5× 356 2.3× 127 1.1× 130 1.3× 14 1.7k
Dan Qu China 17 515 0.6× 175 0.7× 151 1.0× 61 0.5× 68 0.7× 41 1.2k
Caiping Chen China 21 782 0.9× 87 0.3× 215 1.4× 100 0.9× 214 2.2× 68 1.5k
Shengbing Liu China 11 798 0.9× 130 0.5× 252 1.6× 53 0.5× 240 2.4× 17 1.4k

Countries citing papers authored by Bryan Harder

Since Specialization
Citations

This map shows the geographic impact of Bryan Harder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Harder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Harder more than expected).

Fields of papers citing papers by Bryan Harder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Harder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Harder. The network helps show where Bryan Harder may publish in the future.

Co-authorship network of co-authors of Bryan Harder

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Harder. A scholar is included among the top collaborators of Bryan Harder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Harder. Bryan Harder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Weeks, Lachelle D., Danielle Hammond, Sinisa Savic, et al.. (2025). Establishing a consensus definition of VEXAS flare for clinical research. Lara D. Veeken. 65(2).
2.
Oh, Stephen T., Ruben A. Mesa, Claire Harrison, et al.. (2023). Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis. Blood Advances. 7(19). 5835–5842. 39 indexed citations
3.
Harder, Bryan, Sen Peng, Gaspar J. Kitange, et al.. (2019). Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells. Molecular Medicine. 25(1). 49–49. 31 indexed citations
4.
Harder, Bryan, Junwen Wang, Anthony J. Kim, et al.. (2018). Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma. Frontiers in Oncology. 8. 462–462. 113 indexed citations
5.
Hersh, David S., Bryan Harder, Alison Roos, et al.. (2018). The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance. Neuro-Oncology. 20(10). 1321–1330. 31 indexed citations
6.
Dodson, Matthew, Montserrat Rojo de la Vega, Bryan Harder, et al.. (2018). Low-level arsenic causes proteotoxic stress and not oxidative stress. Toxicology and Applied Pharmacology. 341. 106–113. 47 indexed citations
7.
Tillotson, Joseph, et al.. (2017). Arsenic Compromises Both p97 and Proteasome Functions. Chemical Research in Toxicology. 30(7). 1508–1514. 15 indexed citations
8.
Harder, Bryan, Tian Wang, James J. La Clair, et al.. (2016). Brusatol overcomes chemoresistance through inhibition of protein translation. Molecular Carcinogenesis. 56(5). 1493–1500. 107 indexed citations
9.
Long, Min, et al.. (2016). Reduced Nrf2 expression mediates the decline in neural stem cell function during a critical middle‐age period. Aging Cell. 15(4). 725–736. 82 indexed citations
10.
Jiang, Tao, Bryan Harder, Montserrat Rojo de la Vega, et al.. (2015). p62 links autophagy and Nrf2 signaling. Free Radical Biology and Medicine. 88(Pt B). 199–204. 522 indexed citations breakdown →
11.
Harder, Bryan, Tao Jiang, Tongde Wu, et al.. (2015). Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention. Biochemical Society Transactions. 43(4). 680–686. 149 indexed citations
12.
Canet, Mark J., Matthew D. Merrell, Bryan Harder, et al.. (2014). Identification of a Functional Antioxidant Response Element within the Eighth Intron of the Human ABCC3 Gene. Drug Metabolism and Disposition. 43(1). 93–99. 19 indexed citations
14.
Wu, Tongde, Bryan Harder, Pak Kin Wong, Julie E. Lang, & Donna D. Zhang. (2014). Oxidative stress, mammospheres and Nrf2–new implication for breast cancer therapy?. Molecular Carcinogenesis. 54(11). 1494–1502. 93 indexed citations
16.
Pentkowski, Nathan S., Bryan Harder, Ryan M. Bastle, et al.. (2013). Pharmacological Evidence for an Abstinence-Induced Switch in 5-HT1BReceptor Modulation of Cocaine Self-Administration and Cocaine-Seeking Behavior. ACS Chemical Neuroscience. 5(3). 168–176. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026